BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sardu C, Gambardella J, Morelli MB, Wang X, Marfella R, Santulli G. Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? J Clin Med. 2020;9. [PMID: 32403217 DOI: 10.3390/jcm9051417] [Cited by in Crossref: 185] [Cited by in F6Publishing: 191] [Article Influence: 92.5] [Reference Citation Analysis]
Number Citing Articles
1 Yu J, Chai P, Ge S, Fan X. Recent Understandings Toward Coronavirus Disease 2019 (COVID-19): From Bench to Bedside. Front Cell Dev Biol 2020;8:476. [PMID: 32582719 DOI: 10.3389/fcell.2020.00476] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
2 Skeete J, Connell K, Ordunez P, DiPette DJ. Approaches to the Management of Hypertension in Resource-Limited Settings: Strategies to Overcome the Hypertension Crisis in the Post-COVID Era. Integr Blood Press Control 2020;13:125-33. [PMID: 33061561 DOI: 10.2147/IBPC.S261031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
3 Elamari S, Motaib I, Zbiri S, Elaidaoui K, Chadli A, Elkettani C. Characteristics and outcomes of diabetic patients infected by the SARS-CoV-2. Pan Afr Med J 2020;37:32. [PMID: 33209159 DOI: 10.11604/pamj.2020.37.32.25192] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Kalra RS, Dhanjal JK, Meena AS, Kalel VC, Dahiya S, Singh B, Dewanjee S, Kandimalla R. COVID-19, Neuropathology, and Aging: SARS-CoV-2 Neurological Infection, Mechanism, and Associated Complications. Front Aging Neurosci 2021;13:662786. [PMID: 34149397 DOI: 10.3389/fnagi.2021.662786] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Bologna C, Pone E. Clinical Study on the Efficacy and Safety of Arginine Administered Orally in Association with Other Active Ingredients for the Prevention and Treatment of Sarcopenia in Patients with COVID-19-Related Pneumonia, Hospitalized in a Sub-Intensive Care Unit. Healthcare 2022;10:162. [DOI: 10.3390/healthcare10010162] [Reference Citation Analysis]
6 Post A, den Deurwaarder ESG, Bakker SJL, de Haas RJ, van Meurs M, Gansevoort RT, Berger SP. Kidney Infarction in Patients With COVID-19. Am J Kidney Dis 2020;76:431-5. [PMID: 32479921 DOI: 10.1053/j.ajkd.2020.05.004] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 15.5] [Reference Citation Analysis]
7 Pereira GJDS, Leão AHFF, Erustes AG, Morais IBM, Vrechi TAM, Zamarioli LDS, Pereira CAS, Marchioro LO, Sperandio LP, Lins ÍVF, Piacentini M, Fimia GM, Reckziegel P, Smaili SS, Bincoletto C. Pharmacological Modulators of Autophagy as a Potential Strategy for the Treatment of COVID-19. Int J Mol Sci 2021;22:4067. [PMID: 33920748 DOI: 10.3390/ijms22084067] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
8 Natalello G, De Luca G, Gigante L, Campochiaro C, De Lorenzis E, Verardi L, Paglionico A, Petricca L, Martone AM, Calvisi S, Ripa M, Cavalli G, Della-Torre E, Tresoldi M, Landi F, Bosello SL, Gremese E, Dagna L. Nailfold capillaroscopy findings in patients with coronavirus disease 2019: Broadening the spectrum of COVID-19 microvascular involvement. Microvasc Res 2021;133:104071. [PMID: 32949574 DOI: 10.1016/j.mvr.2020.104071] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
9 Namiranian P, Razavi SZE, Karimi M, Ayati MH. Avascular Necrosis in Patients Recovering from COVID-19. Am J Med Sci 2021:S0002-9629(21)00188-9. [PMID: 34033806 DOI: 10.1016/j.amjms.2021.05.018] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Dormoy V, Perotin JM, Gosset P, Maskos U, Polette M, Deslée G. Nicotinic receptors as SARS-CoV-2 spike co-receptors? Med Hypotheses 2022;158:110741. [PMID: 34924680 DOI: 10.1016/j.mehy.2021.110741] [Reference Citation Analysis]
11 Turkia M. COVID-19 As An Endothelial Disease and Its Relationship to Vascular Endothelial Growth Factor (VEGF) and Iodide. SSRN Journal. [DOI: 10.2139/ssrn.3604987] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Otifi HM, Adiga BK. Endothelial Dysfunction in Covid-19. The American Journal of the Medical Sciences 2022. [DOI: 10.1016/j.amjms.2021.12.010] [Reference Citation Analysis]
13 Al-Mulla F, Mohammad A, Al Madhoun A, Haddad D, Ali H, Eaaswarkhanth M, John SE, Nizam R, Channanath A, Abu-Farha M, Ahmad R, Abubaker J, Thanaraj TA. ACE2 and FURIN variants are potential predictors of SARS-CoV-2 outcome: A time to implement precision medicine against COVID-19. Heliyon 2021;7:e06133. [PMID: 33532652 DOI: 10.1016/j.heliyon.2021.e06133] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
14 Trinity JD, Craig JC, Fermoyle CC, McKenzie AI, Lewis MT, Park SH, Rondina MT, Richardson RS. Impact of presymptomatic COVID-19 on vascular and skeletal muscle function: a case study. J Appl Physiol (1985) 2021;130:1961-70. [PMID: 34002634 DOI: 10.1152/japplphysiol.00236.2021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Kaur S, Tripathi DM, Yadav A. The Enigma of Endothelium in COVID-19. Front Physiol 2020;11:989. [PMID: 32848893 DOI: 10.3389/fphys.2020.00989] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 14.0] [Reference Citation Analysis]
16 Glinsky GV. Tripartite Combination of Candidate Pandemic Mitigation Agents: Vitamin D, Quercetin, and Estradiol Manifest Properties of Medicinal Agents for Targeted Mitigation of the COVID-19 Pandemic Defined by Genomics-Guided Tracing of SARS-CoV-2 Targets in Human Cells. Biomedicines 2020;8:E129. [PMID: 32455629 DOI: 10.3390/biomedicines8050129] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 26.0] [Reference Citation Analysis]
17 Gravlee CC. Systemic racism, chronic health inequities, and COVID-19: A syndemic in the making? Am J Hum Biol 2020;32:e23482. [PMID: 32754945 DOI: 10.1002/ajhb.23482] [Cited by in Crossref: 48] [Cited by in F6Publishing: 40] [Article Influence: 24.0] [Reference Citation Analysis]
18 Mukherjee A, Ghosh R, Furment MM. Case Report: COVID-19 Associated Renal Infarction and Ascending Aortic Thrombosis. Am J Trop Med Hyg 2020;103:1989-92. [PMID: 32918409 DOI: 10.4269/ajtmh.20-0869] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
19 Pruc M, Smereka J, Dzieciatkowski T, Jaguszewski M, Filipiak KJ, Szarpak L. Kawasaki disease shock syndrome or toxic shock syndrome in children and the relationship with COVID-19. Med Hypotheses 2020;144:109986. [PMID: 32562912 DOI: 10.1016/j.mehy.2020.109986] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
20 Zhang PL, Liu ML. Extracellular vesicles mediate cellular interactions in renal diseases-Novel views of intercellular communications in the kidney. J Cell Physiol 2021;236:5482-94. [PMID: 33432614 DOI: 10.1002/jcp.30268] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Amar J, Touront N, Ciron AM, Pendaries C. Interactions between hypertension and inflammatory tone and the effect on blood pressure and outcomes in patients with COVID-19. J Clin Hypertens (Greenwich) 2021;23:238-44. [PMID: 33491247 DOI: 10.1111/jch.14137] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Pal N, Weitzel NS, Kertai MD. A Change of Tide or the Beginning of the End: COVID-19. Semin Cardiothorac Vasc Anesth 2021;25:5-10. [PMID: 33554769 DOI: 10.1177/1089253221989132] [Reference Citation Analysis]
23 Liu Y, Garron TM, Chang Q, Su Z, Zhou C, Qiu Y, Gong EC, Zheng J, Yin YW, Ksiazek T, Brasel T, Jin Y, Boor P, Comer JE, Gong B. Cell-Type Apoptosis in Lung during SARS-CoV-2 Infection. Pathogens 2021;10:509. [PMID: 33922476 DOI: 10.3390/pathogens10050509] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Özlü SG, Aydın Z, Bozelli BN, Avcı B, İnözü M, Çaycı FŞ, Gülhan B, Sezer S, Bayrakçı US. Can microalbuminuria be an ındicator of renal ınvolvement in pediatric Covid 19 patients? Infection. [DOI: 10.1007/s15010-021-01745-z] [Reference Citation Analysis]
25 Buijsers B, Yanginlar C, de Nooijer A, Grondman I, Maciej-Hulme ML, Jonkman I, Janssen NAF, Rother N, de Graaf M, Pickkers P, Kox M, Joosten LAB, Nijenhuis T, Netea MG, Hilbrands L, van de Veerdonk FL, Duivenvoorden R, de Mast Q, van der Vlag J. Increased Plasma Heparanase Activity in COVID-19 Patients. Front Immunol 2020;11:575047. [PMID: 33123154 DOI: 10.3389/fimmu.2020.575047] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 10.5] [Reference Citation Analysis]
26 Stute NL, Stickford JL, Province VM, Augenreich MA, Ratchford SM, Stickford ASL. COVID-19 is getting on our nerves: sympathetic neural activity and haemodynamics in young adults recovering from SARS-CoV-2. J Physiol 2021. [PMID: 34174086 DOI: 10.1113/JP281888] [Reference Citation Analysis]
27 Synowiec A, Szczepański A, Barreto-Duran E, Lie LK, Pyrc K. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): a Systemic Infection. Clin Microbiol Rev 2021;34:e00133-20. [PMID: 33441314 DOI: 10.1128/CMR.00133-20] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 13.0] [Reference Citation Analysis]
28 Brar E, Saxena A, Dukler C, Xu F, Saxena D, Cheema Brar P, Guo Y, Li X. Vaping, SARS-CoV-2, and Multisystem Inflammatory Syndrome: A Perfect Storm. Front Pediatr 2021;9:647925. [PMID: 34055688 DOI: 10.3389/fped.2021.647925] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Zhou Y, Huang Y, Song X, Guo X, Pang J, Wang J, Zhang S, Wang C. Single-cell transcriptional profile of ACE2 in healthy and failing human hearts. Sci China Life Sci 2021;64:652-5. [PMID: 32880862 DOI: 10.1007/s11427-020-1787-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
30 Voulalas G, Tsui J, Candilio L, Baker D. SARS-CoV-2 and Pre-existing Vascular Diseases: Guilt by Association? Clin Med Insights Cardiol 2021;15:11795468211010705. [PMID: 34035654 DOI: 10.1177/11795468211010705] [Reference Citation Analysis]
31 Elyaspour Z, Zibaeenezhad MJ, Razmkhah M, Razeghian-Jahromi I. Is It All About Endothelial Dysfunction and Thrombosis Formation? The Secret of COVID-19. Clin Appl Thromb Hemost 2021;27:10760296211042940. [PMID: 34693754 DOI: 10.1177/10760296211042940] [Reference Citation Analysis]
32 Hasan SS, Kow CS, Bain A, Kavanagh S, Merchant HA, Hadi MA. Pharmacotherapeutic considerations for the management of diabetes mellitus among hospitalized COVID-19 patients. Expert Opin Pharmacother. 2021;22:229-240. [PMID: 33054481 DOI: 10.1080/14656566.2020.1837114] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Manzo G. COVID-19 as an Immune Complex Hypersensitivity in Antigen Excess Conditions: Theoretical Pathogenetic Process and Suggestions for Potential Therapeutic Interventions. Front Immunol. 2020;11:566000. [PMID: 33193337 DOI: 10.3389/fimmu.2020.566000] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
34 Uppal NN, Kello N, Shah HH, Khanin Y, De Oleo IR, Epstein E, Sharma P, Larsen CP, Bijol V, Jhaveri KD. De Novo ANCA-Associated Vasculitis With Glomerulonephritis in COVID-19. Kidney Int Rep 2020;5:2079-83. [PMID: 32839744 DOI: 10.1016/j.ekir.2020.08.012] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 11.0] [Reference Citation Analysis]
35 Mone P, Gambardella J, Wang X, Jankauskas SS, Matarese A, Santulli G. miR-24 Targets the Transmembrane Glycoprotein Neuropilin-1 in Human Brain Microvascular Endothelial Cells. Noncoding RNA 2021;7:9. [PMID: 33540664 DOI: 10.3390/ncrna7010009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
36 Bertozzi S, Taricani R, Tulissi I, Patusso F, Amura S, Londero AP. Redesigning doctor-patient relationship in the private health care during COVID-19 pandemic: Retrospective cohort study. Medicine (Baltimore) 2022;101:e28781. [PMID: 35147107 DOI: 10.1097/MD.0000000000028781] [Reference Citation Analysis]
37 Mir N, D'Amico A, Dasher J, Tolwani A, Valentine V. Understanding the andromeda strain - The role of cytokine release, coagulopathy and antithrombin III in SARS-CoV2 critical illness. Blood Rev 2021;45:100731. [PMID: 32829961 DOI: 10.1016/j.blre.2020.100731] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Smirnov AV, Ermilov VV, Dorofeev NA, Tolokolnikov VA, Chernetsky OA, Poplavsky AE, Botasheva VS, Samusev RP, Alexandrova LI, Belik TA, Makarova MM, Gurov DY. [Features of pathological anatomy of COVID-19 according to autopsy results in the Volgograd Region]. Arkh Patol 2021;83:5-13. [PMID: 34859980 DOI: 10.17116/patol2021830615] [Reference Citation Analysis]
39 Sender V, Hentrich K, Henriques-Normark B. Virus-Induced Changes of the Respiratory Tract Environment Promote Secondary Infections With Streptococcus pneumoniae. Front Cell Infect Microbiol 2021;11:643326. [PMID: 33828999 DOI: 10.3389/fcimb.2021.643326] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Liu Y, Garron TM, Chang Q, Su Z, Zhou C, Gong EC, Zheng J, Yin Y, Ksiazek T, Brasel T, Jin Y, Boor P, Comer JE, Gong B. Cell-type apoptosis in lung during SARS-CoV-2 infection. bioRxiv 2020:2020. [PMID: 33398280 DOI: 10.1101/2020.12.23.424254] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
41 Aggarwal R, Dewan A, Pandey A, Trehan N, Majid MA. Efficacy of high-dose intravenous immunoglobulin in severe and critical COVID-19: A retrospective cohort study. International Immunopharmacology 2022;106:108615. [DOI: 10.1016/j.intimp.2022.108615] [Reference Citation Analysis]
42 Kohansal Vajari M, Shirin M, Pourbagheri-Sigaroodi A, Akbari ME, Abolghasemi H, Bashash D. COVID-19-related coagulopathy: A review of pathophysiology and pharmaceutical management. Cell Biol Int 2021. [PMID: 33945651 DOI: 10.1002/cbin.11623] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
43 Yu T, Wang H, Zheng S, Huo L. SARS-CoV-2-Associated Cerebrovascular Disease Amid the COVID-19 Pandemic: A Systematic Review. Infect Drug Resist 2021;14:4967-75. [PMID: 34858037 DOI: 10.2147/IDR.S340314] [Reference Citation Analysis]
44 Porzionato A, Emmi A, Barbon S, Boscolo-Berto R, Stecco C, Stocco E, Macchi V, De Caro R. Sympathetic activation: a potential link between comorbidities and COVID-19. FEBS J 2020;287:3681-8. [PMID: 32779891 DOI: 10.1111/febs.15481] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 11.5] [Reference Citation Analysis]
45 Chahbi M, Bennani M, Massamba N, Sandali O, Tahiri Joutei Hassani R. Mechanisms of retinal damage in patients with COVID-19. J Fr Ophtalmol 2020;43:e355-6. [PMID: 33087252 DOI: 10.1016/j.jfo.2020.07.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Wong DWL, Klinkhammer BM, Djudjaj S, Villwock S, Timm MC, Buhl EM, Wucherpfennig S, Cacchi C, Braunschweig T, Knüchel-Clarke R, Jonigk D, Werlein C, Bülow RD, Dahl E, von Stillfried S, Boor P. Multisystemic Cellular Tropism of SARS-CoV-2 in Autopsies of COVID-19 Patients. Cells 2021;10:1900. [PMID: 34440669 DOI: 10.3390/cells10081900] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
47 Sadeghi A, Moselmi M. Acute lower limb ischemia in an ICU admitted patient diagnosed with the COVID-19: A case report. Clin Case Rep 2021;9:e05146. [PMID: 34917367 DOI: 10.1002/ccr3.5146] [Reference Citation Analysis]
48 Sardu C, Marfella R, Prattichizzo F, La Grotta R, Paolisso G, Ceriello A. Effect of Hyperglycemia on COVID-19 Outcomes: Vaccination Efficacy, Disease Severity, and Molecular Mechanisms. JCM 2022;11:1564. [DOI: 10.3390/jcm11061564] [Reference Citation Analysis]
49 Giordo R, Paliogiannis P, Mangoni AA, Pintus G. SARS-CoV-2 and endothelial cell interaction in COVID-19: molecular perspectives. Vasc Biol 2021;3:R15-23. [PMID: 33659858 DOI: 10.1530/VB-20-0017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
50 Bitencourt L, Pedrosa AL, de Brito SBCS, Fróes ACF, de Carvalho ST, Fonseca GG, Ferreira GC, Fradico PF, Simões E Silva AC. COVID-19 and Renal Diseases: An Update. Curr Drug Targets 2021;22:52-67. [PMID: 33050860 DOI: 10.2174/1389450121999201013151300] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
51 Prasitlumkum N, Chokesuwattanaskul R, Thongprayoon C, Bathini T, Vallabhajosyula S, Cheungpasitporn W. Incidence of Myocardial Injury in COVID-19-Infected Patients: A Systematic Review and Meta-Analysis. Diseases 2020;8:E40. [PMID: 33120956 DOI: 10.3390/diseases8040040] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
52 Sardu C, Marfella R, Maggi P, Messina V, Cirillo P, Codella V, Gambardella J, Sardu A, Gatta G, Santulli G, Paolisso G. Implications of AB0 blood group in hypertensive patients with covid-19. BMC Cardiovasc Disord 2020;20:373. [PMID: 32799852 DOI: 10.1186/s12872-020-01658-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 10.0] [Reference Citation Analysis]
53 Trabulus S, Karaca C, Balkan II, Dincer MT, Murt A, Ozcan SG, Karaali R, Mete B, Bakir A, Kuskucu MA, Altiparmak MR, Tabak F, Seyahi N. Kidney function on admission predicts in-hospital mortality in COVID-19. PLoS One 2020;15:e0238680. [PMID: 32881976 DOI: 10.1371/journal.pone.0238680] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
54 Ong WY, Go ML, Wang DY, Cheah IK, Halliwell B. Effects of Antimalarial Drugs on Neuroinflammation-Potential Use for Treatment of COVID-19-Related Neurologic Complications. Mol Neurobiol 2021;58:106-17. [PMID: 32897518 DOI: 10.1007/s12035-020-02093-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
55 Logan M, Leonard K, Girzadas D Jr. A Case Report of Cerebral Venous Thrombosis as a Complication of Coronavirus Disease 2019 in a Well-appearing Patient. Clin Pract Cases Emerg Med 2021;5:22-5. [PMID: 33560945 DOI: 10.5811/cpcem.2020.11.49633] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Liu L, Chopra P, Li X, Bouwman KM, Tompkins SM, Wolfert MA, de Vries RP, Boons GJ. Heparan Sulfate Proteoglycans as Attachment Factor for SARS-CoV-2. ACS Cent Sci 2021;7:1009-18. [PMID: 34235261 DOI: 10.1021/acscentsci.1c00010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
57 Pannone G, Caponio VCA, De Stefano IS, Ramunno MA, Meccariello M, Agostinone A, Pedicillo MC, Troiano G, Zhurakivska K, Cassano T, Bizzoca ME, Papagerakis S, Buonaguro FM, Advani S, Muzio LL. Lung histopathological findings in COVID-19 disease - a systematic review. Infect Agent Cancer 2021;16:34. [PMID: 34001199 DOI: 10.1186/s13027-021-00369-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
58 Graham EL, Khaja S, Caban-Martinez AJ, Smith DL. Firefighters and COVID-19: An Occupational Health Perspective. J Occup Environ Med 2021;63:e556-63. [PMID: 34138822 DOI: 10.1097/JOM.0000000000002297] [Reference Citation Analysis]
59 Lanza K, Perez LG, Costa LB, Cordeiro TM, Palmeira VA, Ribeiro VT, Simões E Silva AC. Covid-19: the renin-angiotensin system imbalance hypothesis. Clin Sci (Lond) 2020;134:1259-64. [PMID: 32507883 DOI: 10.1042/CS20200492] [Cited by in Crossref: 33] [Cited by in F6Publishing: 17] [Article Influence: 16.5] [Reference Citation Analysis]
60 Jiang L, Tang K, Levin M, Irfan O, Morris SK, Wilson K, Klein JD, Bhutta ZA. COVID-19 and multisystem inflammatory syndrome in children and adolescents. Lancet Infect Dis 2020;20:e276-88. [PMID: 32818434 DOI: 10.1016/S1473-3099(20)30651-4] [Cited by in Crossref: 205] [Cited by in F6Publishing: 121] [Article Influence: 102.5] [Reference Citation Analysis]
61 Bargehr J, Rericha P, Petchey A, Colzani M, Moule G, Malgapo MC, Rassl D, Tarkin J, Mellor G, Sampaziotis F, Brevini T, Gambardella L, Bennett MR, Sinha S. Cardiovascular ACE2 receptor expression in patients undergoing heart transplantation. ESC Heart Fail 2021. [PMID: 34390216 DOI: 10.1002/ehf2.13528] [Reference Citation Analysis]
62 Iaccarino G, Grassi G, Borghi C, Grassi D, Mancusi C, Muiesan ML, Salvetti M, Volpe M, Ferri C. Preexisting Oral Anticoagulant Therapy Ameliorates Prognosis in Hospitalized COVID-19 Patients. Front Cardiovasc Med 2021;8:633878. [PMID: 34055928 DOI: 10.3389/fcvm.2021.633878] [Reference Citation Analysis]
63 Facchiano A, Facchiano F, Facchiano A. An investigation into the molecular basis of cancer comorbidities in coronavirus infection. FEBS Open Bio 2020;10:2363-74. [PMID: 32970391 DOI: 10.1002/2211-5463.12984] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
64 Sabioni L, De Lorenzo A, Lamas C, Muccillo F, Castro-Faria-Neto HC, Estato V, Tibirica E. Systemic microvascular endothelial dysfunction and disease severity in COVID-19 patients: Evaluation by laser Doppler perfusion monitoring and cytokine/chemokine analysis. Microvasc Res 2021;134:104119. [PMID: 33278457 DOI: 10.1016/j.mvr.2020.104119] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
65 Napoli C, Tritto I, Benincasa G, Mansueto G, Ambrosio G. Cardiovascular involvement during COVID-19 and clinical implications in elderly patients. A review. Ann Med Surg (Lond) 2020;57:236-43. [PMID: 32802325 DOI: 10.1016/j.amsu.2020.07.054] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
66 Pérez A, Torregrosa I, D'Marco L, Juan I, Terradez L, Solís MÁ, Moncho F, Carda-Batalla C, Forner MJ, Gorriz JL. IgA-Dominant Infection-Associated Glomerulonephritis Following SARS-CoV-2 Infection. Viruses 2021;13:587. [PMID: 33807151 DOI: 10.3390/v13040587] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
67 Hay M, Barnes C, Huentelman M, Brinton R, Ryan L. Hypertension and Age-Related Cognitive Impairment: Common Risk Factors and a Role for Precision Aging. Curr Hypertens Rep 2020;22:80. [PMID: 32880739 DOI: 10.1007/s11906-020-01090-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
68 Ciccone V, Genah S, Morbidelli L. Endothelium as a Source and Target of H2S to Improve Its Trophism and Function. Antioxidants (Basel) 2021;10:486. [PMID: 33808872 DOI: 10.3390/antiox10030486] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
69 Buhl T, Beissert S, Gaffal E, Goebeler M, Hertl M, Mauch C, Reich K, Schmidt E, Schön MP, Sticherling M, Sunderkötter C, Traidl-Hoffmann C, Werfel T, Wilsman-Theis D, Worm M. COVID-19 and implications for dermatological and allergological diseases. J Dtsch Dermatol Ges 2020;18:815-24. [PMID: 32717116 DOI: 10.1111/ddg.14195] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
70 Agochukwu-Mmonu N, Fendrick AM. The Economics of Viagra Revisited: The Price Is Right. Urology 2021:S0090-4295(21)00457-X. [PMID: 34087316 DOI: 10.1016/j.urology.2021.05.037] [Reference Citation Analysis]
71 García-Mena J, Corona-Cervantes K, Cuervo-Zanatta D, Benitez-Guerrero T, Vélez-Ixta JM, Zavala-Torres NG, Villalobos-Flores LE, Hernández-Quiroz F, Perez-Cruz C, Murugesan S, Bastida-González FG, Zárate-Segura PB. Gut microbiota in a population highly affected by obesity and type 2 diabetes and susceptibility to COVID-19. World J Gastroenterol 2021; 27(41): 7065-7079 [PMID: 34887628 DOI: 10.3748/wjg.v27.i41.7065] [Reference Citation Analysis]
72 Bolevich SB, Bolevich SS. Complex mechanism of COVID-19 development. jour 2020;11:50-61. [DOI: 10.47093/2218-7332.2020.11.2.50-61] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
73 Indari O, Baral B, Muduli K, Mohanty AP, Swain N, Mohakud NK, Jha HC. Insights into Plasmodium and SARS-CoV-2 co-infection driven neurological manifestations. Biosaf Health 2021;3:230-4. [PMID: 33969285 DOI: 10.1016/j.bsheal.2021.04.001] [Reference Citation Analysis]
74 Wang S, Tan Y, Yang T, Liu C, Li R. Pulmonary AngII promotes LPS-induced lung inflammation by regulating microRNA-143. Cytotechnology 2021;:1-10. [PMID: 34493899 DOI: 10.1007/s10616-021-00493-0] [Reference Citation Analysis]
75 Xia F, Zhang M, Cui B, An W, Chen M, Yang P, Qin T, Zhou X, Liao Y, Xu X, Liu S, Li K, Zhou Q, Wang K, Hu G, Du M, Chen S, Zhang Y, Wei W, Xiang M, Zhang J. COVID-19 patients with hypertension are at potential risk of worsened organ injury. Sci Rep 2021;11:3779. [PMID: 33580165 DOI: 10.1038/s41598-021-83295-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
76 Tiscia GL, Favuzzi G, De Laurenzo A, Cappucci F, Fischetti L, di Mauro L, Miscio G, Mirijello A, Chinni E, Grandone E; CSS COVID-19 Group . Reduction of ADAMTS13 Levels Predicts Mortality in SARS-CoV-2 Patients. TH Open 2020;4:e203-6. [PMID: 32879905 DOI: 10.1055/s-0040-1716379] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
77 Yoganandamoorthy S, Munasinghe MADSN, Wanigasuriya LVU, Priyankara MKK, Jayasinghe S. Non-invasive assessment of endothelial dysfunction: A novel method to predict severe COVID-19? Med Hypotheses 2020;144:110229. [PMID: 33254535 DOI: 10.1016/j.mehy.2020.110229] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
78 He Y, Sun J, Ding X, Wang Q. Mechanisms in Which Smoking Increases the Risk of COVID-19 Infection: A Narrative Review. Iran J Public Health 2021;50:431-7. [PMID: 34178790 DOI: 10.18502/ijph.v50i3.5582] [Reference Citation Analysis]
79 Li D, Chen P, Shi T, Mehmood A, Qiu J. HD5 and LL-37 Inhibit SARS-CoV and SARS-CoV-2 Binding to Human ACE2 by Molecular Simulation. Interdiscip Sci 2021. [PMID: 34363600 DOI: 10.1007/s12539-021-00462-3] [Reference Citation Analysis]
80 Felldin M, Søfteland JM, Magnusson J, Ekberg J, Karason K, Schult A, Larsson H, Oltean M, Friman V. Initial Report From a Swedish High-volume Transplant Center After the First Wave of the COVID-19 Pandemic. Transplantation 2021;105:108-14. [PMID: 32826796 DOI: 10.1097/TP.0000000000003436] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 12.0] [Reference Citation Analysis]
81 Tonyan ZN, Nasykhova YA, Danilova MM, Glotov AS. Genetics of macrovascular complications in type 2 diabetes. World J Diabetes 2021; 12(8): 1200-1219 [PMID: 34512887 DOI: 10.4239/wjd.v12.i8.1200] [Reference Citation Analysis]
82 MacLean MA, Kamintsky L, Leck ED, Friedman A. The potential role of microvascular pathology in the neurological manifestations of coronavirus infection. Fluids Barriers CNS 2020;17:55. [PMID: 32912226 DOI: 10.1186/s12987-020-00216-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
83 Manti S, Parisi GF, Papale M, Mulè E, Aloisio D, Rotolo N, Leonardi S. Looking beyond pulmonary disease in COVID-19: A lesson from patients with cystic fibrosis. Med Hypotheses 2021;147:110481. [PMID: 33421691 DOI: 10.1016/j.mehy.2020.110481] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
84 Cui R, Zhu Y, Wang Y, Chen XH, Li Q, Dai SM, Tong Q. Tocilizumab in the treatment of coronavirus disease 2019 pneumonia: real-world data from a case series. Future Virol 2021. [PMID: 34055031 DOI: 10.2217/fvl-2020-0410] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
85 Maggi P, Ricci E, Messina V, Salzillo A, Simeone F, Iodice A, Socio GV. Dangerous liaisons? The role of inflammation and comorbidities in HIV and SARS-CoV-2 infection. Expert Rev Clin Immunol 2021;17:201-8. [PMID: 33538189 DOI: 10.1080/1744666X.2021.1886080] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
86 Spogis J, Hagen F, Thaiss WM, Hoffmann T, Malek N, Nikolaou K, Berg CP, Singer S, Bösmüller H, Kreth F, Kaufmann S. Sonographic findings in coronavirus disease-19 associated liver damage. PLoS One 2021;16:e0244781. [PMID: 33606703 DOI: 10.1371/journal.pone.0244781] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
87 Citi V, Martelli A, Brancaleone V, Brogi S, Gojon G, Montanaro R, Morales G, Testai L, Calderone V. Anti-inflammatory and antiviral roles of hydrogen sulfide: Rationale for considering H2 S donors in COVID-19 therapy. Br J Pharmacol 2020;177:4931-41. [PMID: 32783196 DOI: 10.1111/bph.15230] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
88 Ramezankhani R, Solhi R, Memarnejadian A, Nami F, Hashemian SMR, Tricot T, Vosough M, Verfaillie C. Therapeutic modalities and novel approaches in regenerative medicine for COVID-19. Int J Antimicrob Agents 2020;56:106208. [PMID: 33213829 DOI: 10.1016/j.ijantimicag.2020.106208] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
89 D'Souza R, Malhamé I, Teshler L, Acharya G, Hunt BJ, McLintock C. A critical review of the pathophysiology of thrombotic complications and clinical practice recommendations for thromboprophylaxis in pregnant patients with COVID-19. Acta Obstet Gynecol Scand 2020;99:1110-20. [PMID: 32678949 DOI: 10.1111/aogs.13962] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 10.5] [Reference Citation Analysis]
90 Conway J, Gould A, Westley R, Raju SA, Oklopcic A, Broadbent A, Abdelhafiz AH, Sinclair AJ. Characteristics of patients with diabetes hospitalised for COVID-19 infection-a brief case series report. Diabetes Res Clin Pract 2020;169:108460. [PMID: 32971153 DOI: 10.1016/j.diabres.2020.108460] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
91 Gambardella J, Khondkar W, Morelli MB, Wang X, Santulli G, Trimarco V. Arginine and Endothelial Function. Biomedicines 2020;8:E277. [PMID: 32781796 DOI: 10.3390/biomedicines8080277] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
92 García-Cervera C, Giner-Galvañ V, Wikman-Jorgensen P, Laureiro J, Rubio-Rivas M, Gurjian Arena A, Arnalich-Fernandez F, Beato Pérez JL, Vargas Núñez JA, González Igual JJ, Díez-Manglano J, Méndez Bailón M, García Blanco MJ, Freire Castro SJ, Aranda Lobo J, Manzano L, Magallanes Gamboa JO, Arribas Pérez L, González Moraleja J, Calderón Hernaiz R, García Alegría J, González Noya A, Gómez Huelgas R, Lumbreras Bermejo C, Antón Santos JM; SEMI-COVID-19 Network. Estimation of Admission D-dimer Cut-off Value to Predict Venous Thrombotic Events in Hospitalized COVID-19 Patients: Analysis of the SEMI-COVID-19 Registry. J Gen Intern Med 2021. [PMID: 34287774 DOI: 10.1007/s11606-021-07017-8] [Reference Citation Analysis]
93 Candeloro E, Carimati F, Tabaee Damavandi P, Princiotta Cariddi L, Banfi P, Clemenzi A, Gallazzi M, Mauri M, Rebecchi V, Baruzzi F, Giorgianni A, Tozzi M, Bianchi M, Ageno W, Versino M. An Example of a Stroke Unit Reshaping in the Context of a Regional Hub and Spoke System in the COVID-19 Era. Front Neurol 2020;11:1029. [PMID: 33178094 DOI: 10.3389/fneur.2020.01029] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
94 Loganathan S, Athalye SN, Joshi SR. Itolizumab, an anti-CD6 monoclonal antibody, as a potential treatment for COVID-19 complications. Expert Opinion on Biological Therapy 2020;20:1025-31. [DOI: 10.1080/14712598.2020.1798399] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
95 Horii T, Fujioka T, Takahashi M, Mori M, Tsuchiya J, Yamaga E, Yamada H, Kimura M, Kishino M, Tateishi U. Late-onset pneumothorax in a COVID-19 patient treated with ventilation and ECMO: A case report and literature review. Radiol Case Rep 2020;15:2560-4. [PMID: 32989407 DOI: 10.1016/j.radcr.2020.09.036] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
96 Matarese A, Gambardella J, Sardu C, Santulli G. miR-98 Regulates TMPRSS2 Expression in Human Endothelial Cells: Key Implications for COVID-19. Biomedicines 2020;8:E462. [PMID: 33143053 DOI: 10.3390/biomedicines8110462] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 11.5] [Reference Citation Analysis]
97 Hasselbalch HC, Skov V, Kjær L, Ellervik C, Poulsen A, Poulsen TD, Nielsen CH. COVID-19 as a mediator of interferon deficiency and hyperinflammation: Rationale for the use of JAK1/2 inhibitors in combination with interferon. Cytokine Growth Factor Rev 2021;60:28-45. [PMID: 33992887 DOI: 10.1016/j.cytogfr.2021.03.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
98 Liu Y, Zhang HG. Vigilance on New-Onset Atherosclerosis Following SARS-CoV-2 Infection. Front Med (Lausanne) 2020;7:629413. [PMID: 33553222 DOI: 10.3389/fmed.2020.629413] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
99 Tharmalingam H, Díez P, Tsang Y, Hawksley A, Conibear J, Thiruthaneeswaran N. Personal View: Low-dose Lung Radiotherapy for COVID-19 Pneumonia - The Atypical Science and the Unknown Collateral Consequence. Clin Oncol (R Coll Radiol) 2020;32:497-500. [PMID: 32536559 DOI: 10.1016/j.clon.2020.06.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
100 González González F, Cortés Correa C, Peñaranda Contreras E. Cutaneous Manifestations in Patients With COVID-19: Clinical Characteristics and Possible Pathophysiologic Mechanisms. Actas Dermosifiliogr 2021;112:314-23. [PMID: 34012165 DOI: 10.1016/j.adengl.2021.01.024] [Reference Citation Analysis]
101 Losso JN, Losso MN, Toc M, Inungu JN, Finley JW. The Young Age and Plant-Based Diet Hypothesis for Low SARS-CoV-2 Infection and COVID-19 Pandemic in Sub-Saharan Africa. Plant Foods Hum Nutr 2021. [PMID: 34169470 DOI: 10.1007/s11130-021-00907-6] [Reference Citation Analysis]
102 Oyagbemi AA, Ajibade TO, Aboua YG, Gbadamosi IT, Adedapo ADA, Aro AO, Adejumobi OA, Thamahane-Katengua E, Omobowale TO, Falayi OO, Oyagbemi TO, Ogunpolu BS, Hassan FO, Ogunmiluyi IO, Ola-Davies OE, Saba AB, Adedapo AA, Nkadimeng SM, McGaw LJ, Kayoka-Kabongo PN, Yakubu MA, Oguntibeju OO. The therapeutic potential of the novel angiotensin-converting enzyme 2 in the treatment of coronavirus disease-19. Vet World 2021;14:2705-13. [PMID: 34903929 DOI: 10.14202/vetworld.2021.2705-2713] [Reference Citation Analysis]
103 Rotoli BM, Barilli A, Visigalli R, Ferrari F, Dall'Asta V. Endothelial Cell Activation by SARS-CoV-2 Spike S1 Protein: A Crosstalk between Endothelium and Innate Immune Cells. Biomedicines 2021;9:1220. [PMID: 34572407 DOI: 10.3390/biomedicines9091220] [Reference Citation Analysis]
104 Viswanathan V, Puvvula A, Jamthikar AD, Saba L, Johri AM, Kotsis V, Khanna NN, Dhanjil SK, Majhail M, Misra DP, Agarwal V, Kitas GD, Sharma AM, Kolluri R, Naidu S, Suri JS. Bidirectional link between diabetes mellitus and coronavirus disease 2019 leading to cardiovascular disease: A narrative review. World J Diabetes 2021; 12(3): 215-237 [PMID: 33758644 DOI: 10.4239/wjd.v12.i3.215] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
105 Wee AKH. COVID-19's toll on the elderly and those with diabetes mellitus - Is vitamin B12 deficiency an accomplice? Med Hypotheses 2021;146:110374. [PMID: 33257090 DOI: 10.1016/j.mehy.2020.110374] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
106 Pavel A, Del Giudice G, Federico A, Di Lieto A, Kinaret PAS, Serra A, Greco D. Integrated network analysis reveals new genes suggesting COVID-19 chronic effects and treatment. Brief Bioinform 2021;22:1430-41. [PMID: 33569598 DOI: 10.1093/bib/bbaa417] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
107 Klouda T, Hao Y, Kim H, Kim J, Olejnik J, Hume AJ, Ayyappan S, Hong X, Melero-Martin J, Fang Y, Wang Q, Zhou X, Mühlberger E, Jia H, Padera RF Jr, Raby BA, Yuan K. Interferon-alpha or -beta facilitates SARS-CoV-2 pulmonary vascular infection by inducing ACE2. Angiogenesis 2021. [PMID: 34714440 DOI: 10.1007/s10456-021-09823-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
108 Aslam M, Ladilov Y. Targeting the sAC-Dependent cAMP Pool to Prevent SARS-Cov-2 Infection. Cells 2020;9:E1962. [PMID: 32854430 DOI: 10.3390/cells9091962] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
109 Syahrul S, Maliga HA, Ilmawan M, Fahriani M, Mamada SS, Fajar JK, Frediansyah A, Syahrul FN, Imran I, Haris S, Rambe AS, Emran TB, Rabaan AA, Tiwari R, Dhama K, Nainu F, Mutiawati E, Harapan H. Hemorrhagic and ischemic stroke in patients with coronavirus disease 2019: incidence, risk factors, and pathogenesis - a systematic review and meta-analysis. F1000Res 2021;10:34. [PMID: 33708378 DOI: 10.12688/f1000research.42308.1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
110 Milenkovic D, Ruskovska T, Rodriguez-Mateos A, Heiss C. Polyphenols Could Prevent SARS-CoV-2 Infection by Modulating the Expression of miRNAs in the Host Cells. Aging Dis 2021;12:1169-82. [PMID: 34341700 DOI: 10.14336/AD.2021.0223] [Reference Citation Analysis]
111 Buhl T, Beissert S, Gaffal E, Goebeler M, Hertl M, Mauch C, Reich K, Schmidt E, Schön MP, Sticherling M, Sunderkötter C, Traidl-Hoffmann C, Werfel T, Wilsman-Theis D, Worm M. COVID‐19 und Auswirkungen auf dermatologische und allergologische Erkrankungen. J Dtsch Dermatol Ges 2020;18:815-25. [PMID: 32881343 DOI: 10.1111/ddg.14195_g] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
112 [DOI: 10.1101/2020.07.25.221036] [Cited by in Crossref: 16] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
113 Loo J, Spittle DA, Newnham M. COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms. Thorax 2021;76:412-20. [PMID: 33408195 DOI: 10.1136/thoraxjnl-2020-216243] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 25.0] [Reference Citation Analysis]
114 Gambardella J, Santulli G. What is linking COVID-19 and endothelial dysfunction? Updates on nanomedicine and bioengineering from the 2020 AHA Scientific Sessions. Eur Heart J Cardiovasc Pharmacother 2021;7:e2-3. [PMID: 33377481 DOI: 10.1093/ehjcvp/pvaa145] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
115 Martínez-Murillo C, Ramos Peñafiel C, Basurto L, Balcázar-Hernández L, Pellón K, Flores López E, Li Gómez B, Ledesma ME, Rivera Tapia R, Madera Maldonado E, Bejarano Rosales M, Barranco Lampon G, Zazueta JF. COVID-19 in a country with a very high prevalence of diabetes: The impact of admission hyperglycaemia on mortality. Endocrinol Diabetes Metab 2021;4:e00279. [PMID: 34277995 DOI: 10.1002/edm2.279] [Reference Citation Analysis]
116 Hay M, Ryan L, Huentelman M, Konhilas J, Hoyer-Kimura C, Beach TG, Serrano GE, Reiman EM, Blennow K, Zetterberg H, Parthasarathy S. Serum Neurofilament Light is elevated in COVID-19 Positive Adults in the ICU and is associated with Co-Morbid Cardiovascular Disease, Neurological Complications, and Acuity of Illness. Cardiol Cardiovasc Med 2021;5:551-65. [PMID: 34708189 DOI: 10.26502/fccm.92920221] [Reference Citation Analysis]
117 Zinovkin RA, Grebenchikov OA. Transcription Factor Nrf2 as a Potential Therapeutic Target for Prevention of Cytokine Storm in COVID-19 Patients.Biochemistry (Mosc). 2020;85:833-837. [PMID: 33040727 DOI: 10.1134/S0006297920070111] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
118 Sackner MA, Adams JA. Endothelial pulsatile shear stress is a backstop for COVID-19. Emerg Top Life Sci 2020;4:379-87. [PMID: 33200786 DOI: 10.1042/ETLS20200260] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
119 Abu-Farha M, Al-Mulla F, Thanaraj TA, Kavalakatt S, Ali H, Abdul Ghani M, Abubaker J. Impact of Diabetes in Patients Diagnosed With COVID-19. Front Immunol 2020;11:576818. [PMID: 33335527 DOI: 10.3389/fimmu.2020.576818] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]
120 Suvorava T, Kaesemeyer W. Targeting the Vascular Endothelium in the Treatment of COVID-19. J Cardiovasc Pharmacol 2021;77:1-3. [PMID: 33079828 DOI: 10.1097/FJC.0000000000000932] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
121 Mohamed S, Saad K, Elgohary G, Abdelhaffez A, El-aziz NA. Is COVID-19 a Systemic Disease? COVID 2021;2:4-8. [DOI: 10.2174/2666796701999201216101914] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
122 Barbiero P, Viñas Torné R, Lió P. Graph Representation Forecasting of Patient's Medical Conditions: Toward a Digital Twin. Front Genet 2021;12:652907. [PMID: 34603366 DOI: 10.3389/fgene.2021.652907] [Reference Citation Analysis]
123 Vianello A, Guarnieri G, Braccioni F, Lococo S, Molena B, Cecchetto A, Giraudo C, Bertagna De Marchi L, Caminati M, Senna G. The pathogenesis, epidemiology and biomarkers of susceptibility of pulmonary fibrosis in COVID-19 survivors. Clin Chem Lab Med 2021. [PMID: 34783228 DOI: 10.1515/cclm-2021-1021] [Reference Citation Analysis]
124 Funk CD, Laferrière C, Ardakani A. A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic. Front Pharmacol 2020;11:937. [PMID: 32636754 DOI: 10.3389/fphar.2020.00937] [Cited by in Crossref: 78] [Cited by in F6Publishing: 60] [Article Influence: 39.0] [Reference Citation Analysis]
125 Arab AZ, Conti AA, Davey F, Khan F, Baldacchino AM. Relationship Between Cardiovascular Disease Pathology and Fatal Opioid and Other Sedative Overdose: A Post-Mortem Investigation and Pilot Study. Front Pharmacol 2021;12:725034. [PMID: 34803676 DOI: 10.3389/fphar.2021.725034] [Reference Citation Analysis]
126 Ortega MA, Fraile-Martínez O, García-Montero C, García-Gallego S, Sánchez-Trujillo L, Torres-Carranza D, Álvarez-Mon MÁ, Pekarek L, García-Honduvilla N, Bujan J, Álvarez-Mon M, Asúnsolo Á, De la Torre B. An integrative look at SARS‑CoV‑2 (Review). Int J Mol Med 2021;47:415-34. [PMID: 33416095 DOI: 10.3892/ijmm.2020.4828] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
127 Pandanaboyana S, Moir J, Leeds JS, Oppong K, Kanwar A, Marzouk A, Belgaumkar A, Gupta A, Siriwardena AK, Haque AR, Awan A, Balakrishnan A, Rawashdeh A, Ivanov B, Parmar C, M Halloran C, Caruana C, Borg CM, Gomez D, Damaskos D, Karavias D, Finch G, Ebied H, K Pine J, R A Skipworth J, Milburn J, Latif J, Ratnam Apollos J, El Kafsi J, Windsor JA, Roberts K, Wang K, Ravi K, V Coats M, Hollyman M, Phillips M, Okocha M, Sj Wilson M, A Ameer N, Kumar N, Shah N, Lapolla P, Magee C, Al-Sarireh B, Lunevicius R, Benhmida R, Singhal R, Balachandra S, Demirli Atıcı S, Jaunoo S, Dwerryhouse S, Boyce T, Charalampakis V, Kanakala V, Abbas Z, Nayar M; COVID PAN collaborative group. SARS-CoV-2 infection in acute pancreatitis increases disease severity and 30-day mortality: COVID PAN collaborative study. Gut 2021;70:1061-9. [PMID: 33547182 DOI: 10.1136/gutjnl-2020-323364] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
128 Saeed S, Mancia G. Arterial stiffness and COVID-19: A bidirectional cause-effect relationship. J Clin Hypertens (Greenwich) 2021;23:1099-103. [PMID: 33951308 DOI: 10.1111/jch.14259] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
129 He C, Liu C, Yang J, Tan H, Ding X, Gao X, Yang Y, Shen Y, Xiang H, Ke J, Yuan F, Chen R, Cheng R, Lv H, Li P, Zhang L, Huang L. Prognostic significance of day‐by‐day in‐hospital blood pressure variability in COVID‐19 patients with hypertension. J of Clinical Hypertension. [DOI: 10.1111/jch.14437] [Reference Citation Analysis]
130 Schimmel L, Chew KY, Stocks CJ, Yordanov TE, Essebier P, Kulasinghe A, Monkman J, Dos Santos Miggiolaro AFR, Cooper C, de Noronha L, Schroder K, Lagendijk AK, Labzin LI, Short KR, Gordon EJ. Endothelial cells are not productively infected by SARS-CoV-2. Clin Transl Immunology 2021;10:e1350. [PMID: 34721846 DOI: 10.1002/cti2.1350] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
131 Borah P, Deb PK, Chandrasekaran B, Goyal M, Bansal M, Hussain S, Shinu P, Venugopala KN, Al-Shar'i NA, Deka S, Singh V. Neurological Consequences of SARS-CoV-2 Infection and Concurrence of Treatment-Induced Neuropsychiatric Adverse Events in COVID-19 Patients: Navigating the Uncharted. Front Mol Biosci 2021;8:627723. [PMID: 33681293 DOI: 10.3389/fmolb.2021.627723] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
132 Sardu C, Maggi P, Messina V, Iuliano P, Sardu A, Iovinella V, Paolisso G, Marfella R. Could Anti-Hypertensive Drug Therapy Affect the Clinical Prognosis of Hypertensive Patients With COVID-19 Infection? J Am Heart Assoc. 2020;9:e016948. [PMID: 32633594 DOI: 10.1161/jaha.120.016948] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 19.0] [Reference Citation Analysis]
133 Abramczyk U, Kuzan A. What Every Diabetologist Should Know about SARS-CoV-2: State of Knowledge at the Beginning of 2021. J Clin Med 2021;10:1022. [PMID: 33801468 DOI: 10.3390/jcm10051022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
134 Huang J, Liu X, Wu Z, Zhang L, Yang X. Improving staff safety with checklists during novel coronavirus disease (COVID-19) pandemic: A quasi-experiment study in vascular surgical department. Medicine (Baltimore) 2020;99:e21548. [PMID: 32769893 DOI: 10.1097/MD.0000000000021548] [Reference Citation Analysis]
135 Kotlyar AM, Grechukhina O, Chen A, Popkhadze S, Grimshaw A, Tal O, Taylor HS, Tal R. Vertical transmission of coronavirus disease 2019: a systematic review and meta-analysis. Am J Obstet Gynecol 2021;224:35-53.e3. [PMID: 32739398 DOI: 10.1016/j.ajog.2020.07.049] [Cited by in Crossref: 110] [Cited by in F6Publishing: 100] [Article Influence: 55.0] [Reference Citation Analysis]
136 Mihaila RG, Dragos Mihaila M. Coagulation disorders in SARS-CoV-2 infection. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2020. [PMID: 32901615 DOI: 10.5507/bp.2020.037] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
137 Xiao YF, He JL, Xu Y, Liu X, Lin H, Li Q, Xu Z, Hu MD, Ren XB, Zhang C, Zhang WJ, Duan W, Tian YF, Li P, Wu H, Song CP, Liu E, Yang SM. Major Characteristics of Severity and Mortality in Diabetic Patients With COVID-19 and Establishment of Severity Risk Score. Front Med (Lausanne) 2021;8:655604. [PMID: 34164413 DOI: 10.3389/fmed.2021.655604] [Reference Citation Analysis]
138 Morelli MB, Gambardella J, Castellanos V, Trimarco V, Santulli G. Vitamin C and Cardiovascular Disease: An Update. Antioxidants (Basel) 2020;9:E1227. [PMID: 33287462 DOI: 10.3390/antiox9121227] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
139 Carubbi F, Salvati L, Alunno A, Maggi F, Borghi E, Mariani R, Mai F, Paoloni M, Ferri C, Desideri G, Cicogna S, Grassi D. Ferritin is associated with the severity of lung involvement but not with worse prognosis in patients with COVID-19: data from two Italian COVID-19 units. Sci Rep 2021;11:4863. [PMID: 33649408 DOI: 10.1038/s41598-021-83831-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
140 Golubev AG. COVID-19: A Challenge to Physiology of Aging. Front Physiol 2020;11:584248. [PMID: 33343386 DOI: 10.3389/fphys.2020.584248] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
141 Reinstadler SJ, Reindl M, Lechner I, Holzknecht M, Tiller C, Roithinger FX, Frick M, Hoppe UC, Jirak P, Berger R, Delle-Karth G, Laßnig E, Klug G, Bauer A, Binder R, Metzler B. Effect of the COVID-19 Pandemic on Treatment Delays in Patients with ST-Segment Elevation Myocardial Infarction. J Clin Med 2020;9:E2183. [PMID: 32664309 DOI: 10.3390/jcm9072183] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
142 Mitchell EP. COVID-19 Innovations: Addressing Rapidly Changing Clinical Needs. J Natl Med Assoc 2020;112:237-8. [PMID: 32709271 DOI: 10.1016/j.jnma.2020.06.004] [Reference Citation Analysis]
143 Özdemir İH, Özlek B, Burak Özen M, Gündüz R, Çetin N. Prognostic implication of uncontrolled hypertension in hospitalized patients with COVID-19. Cor Vasa 2021;63:668-73. [DOI: 10.33678/cor.2021.062] [Reference Citation Analysis]
144 Santaolalla A, Beckmann K, Kibaru J, Josephs D, Van Hemelrijck M, Irshad S. Association Between Vitamin D and Novel SARS-CoV-2 Respiratory Dysfunction - A Scoping Review of Current Evidence and Its Implication for COVID-19 Pandemic. Front Physiol 2020;11:564387. [PMID: 33324234 DOI: 10.3389/fphys.2020.564387] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
145 Alam MS, Czajkowsky DM. SARS-CoV-2 infection and oxidative stress: Pathophysiological insight into thrombosis and therapeutic opportunities. Cytokine Growth Factor Rev 2021:S1359-6101(21)00080-0. [PMID: 34836751 DOI: 10.1016/j.cytogfr.2021.11.001] [Reference Citation Analysis]
146 Martelli A, Citi V, Calderone V. Recent efforts in drug discovery on vascular inflammation and consequent atherosclerosis. Expert Opin Drug Discov 2021;16:411-27. [PMID: 33256484 DOI: 10.1080/17460441.2021.1850688] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
147 Zhang S, Zhang J, Wang C, Chen X, Zhao X, Jing H, Liu H, Li Z, Wang L, Shi J. COVID‑19 and ischemic stroke: Mechanisms of hypercoagulability (Review). Int J Mol Med 2021;47:21. [PMID: 33448315 DOI: 10.3892/ijmm.2021.4854] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
148 Planchuelo-Gómez Á, Trigo J, de Luis-García R, Guerrero ÁL, Porta-Etessam J, García-Azorín D. Deep Phenotyping of Headache in Hospitalized COVID-19 Patients via Principal Component Analysis. Front Neurol 2020;11:583870. [PMID: 33391152 DOI: 10.3389/fneur.2020.583870] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
149 Panfoli I. Potential role of endothelial cell surface ectopic redox complexes in COVID-19 disease pathogenesis. Clin Med (Lond) 2020;20:e146-7. [PMID: 32601125 DOI: 10.7861/clinmed.2020-0252] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
150 Marfella R, Paolisso P, Sardu C, Palomba L, D'Onofrio N, Cesaro A, Barbieri M, Rizzo MR, Sasso FC, Scisciola L, Turriziani F, Galdiero M, Pignataro D, Minicucci F, Trotta MC, D'Amico M, Mauro C, Calabrò P, Balestrieri ML, Signioriello G, Barbato E, Galdiero M, Paolisso G. SARS-COV-2 colonizes coronary thrombus and impairs heart microcirculation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction. Crit Care 2021;25:217. [PMID: 34167575 DOI: 10.1186/s13054-021-03643-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
151 Marchandot B, Sattler L, Jesel L, Matsushita K, Schini-Kerth V, Grunebaum L, Morel O. COVID-19 Related Coagulopathy: A Distinct Entity? J Clin Med 2020;9:E1651. [PMID: 32486469 DOI: 10.3390/jcm9061651] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 25.5] [Reference Citation Analysis]
152 Mone P, Gambardella J, Wang X, Jankauskas SS, Matarese A, Santulli G. miR-24 targets SARS-CoV-2 co-factor Neuropilin-1 in human brain microvascular endothelial cells: Insights for COVID-19 neurological manifestations. Res Sq 2021:rs. [PMID: 33564755 DOI: 10.21203/rs.3.rs-192099/v1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
153 Mangion K, Morrow A, Bagot C, Bayes H, Blyth KG, Church C, Corcoran D, Delles C, Gillespie L, Grieve D, Ho A, Kean S, Lang NN, Lennie V, Lowe DJ, Kellman P, Macfarlane PW, McConnachie A, Roditi G, Sykes R, Touyz RM, Sattar N, Wereski R, Wright S, Berry C. The Chief Scientist Office Cardiovascular and Pulmonary Imaging in SARS Coronavirus disease-19 (CISCO-19) study. Cardiovasc Res 2020;116:2185-96. [PMID: 32702087 DOI: 10.1093/cvr/cvaa209] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
154 Verma AK, Beg MMA, Bhatt D, Dev K, Alsahli MA, Rahmani AH, Goyal Y. Assessment and Management of Diabetic Patients During the COVID-19 Pandemic. Diabetes Metab Syndr Obes 2021;14:3131-46. [PMID: 34262317 DOI: 10.2147/DMSO.S285614] [Reference Citation Analysis]
155 Añazco PH, Balta FM, Córdova-Cueva L. Bilateral renal infarction in a patient with severe COVID-19 infection. J Bras Nefrol 2021;43:127-31. [PMID: 33460428 DOI: 10.1590/2175-8239-JBN-2020-0156] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
156 Davidescu EI, Odajiu I, Tulbǎ D, Sandu CD, Bunea T, Sandu G, Mureşanu DF, Bǎlǎnescu P, Popescu BO. Prognostic Factors in COVID-19 Patients With New Neurological Manifestations: A Retrospective Cohort Study in a Romanian Neurology Department. Front Aging Neurosci 2021;13:645611. [PMID: 34220483 DOI: 10.3389/fnagi.2021.645611] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
157 Funk CD, Ardakani A. A Novel Strategy to Mitigate the Hyperinflammatory Response to COVID-19 by Targeting Leukotrienes. Front Pharmacol 2020;11:1214. [PMID: 32848802 DOI: 10.3389/fphar.2020.01214] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
158 Ruzzenenti G, Maloberti A, Giani V, Biolcati M, Leidi F, Monticelli M, Grasso E, Cartella I, Palazzini M, Garatti L, Ughi N, Rossetti C, Epis OM, Giannattasio C; Covid-19 Niguarda Working Group. Covid and Cardiovascular Diseases: Direct and Indirect Damages and Future Perspective. High Blood Press Cardiovasc Prev 2021. [PMID: 34173942 DOI: 10.1007/s40292-021-00464-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
159 Hage R, Steinack C, Gautschi F, Pfister S, Inci I, Schuurmans MM. Clinical Characteristics, Treatments and Outcomes of 18 Lung Transplant Recipients with COVID-19. Transplantology 2021;2:229-45. [DOI: 10.3390/transplantology2020022] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
160 Nannoni S, de Groot R, Bell S, Markus HS. Stroke in COVID-19: A systematic review and meta-analysis. Int J Stroke 2021;16:137-49. [PMID: 33103610 DOI: 10.1177/1747493020972922] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 18.0] [Reference Citation Analysis]
161 Kasal DA, De Lorenzo A, Tibiriçá E. COVID-19 and Microvascular Disease: Pathophysiology of SARS-CoV-2 Infection With Focus on the Renin-Angiotensin System. Heart Lung Circ 2020;29:1596-602. [PMID: 32972810 DOI: 10.1016/j.hlc.2020.08.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
162 Bernard I, Limonta D, Mahal LK, Hobman TC. Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19. Viruses 2020;13:E29. [PMID: 33375371 DOI: 10.3390/v13010029] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 11.5] [Reference Citation Analysis]
163 Mancusi C, Grassi G, Borghi C, Ferri C, Muiesan ML, Volpe M, Iaccarino G; SARS-RAS Investigator Group. Clinical Characteristics and Outcomes of Patients with COVID-19 Infection: The Results of the SARS-RAS Study of the Italian Society of Hypertension. High Blood Press Cardiovasc Prev 2021;28:5-11. [PMID: 33471297 DOI: 10.1007/s40292-020-00429-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
164 Qi X, Kong H, Ding W, Wu C, Ji N, Huang M, Li T, Wang X, Wen J, Wu W, Wu M, Huang C, Li Y, Liu Y, Tang J. Abnormal Coagulation Function of Patients With COVID-19 Is Significantly Related to Hypocalcemia and Severe Inflammation. Front Med (Lausanne) 2021;8:638194. [PMID: 34222271 DOI: 10.3389/fmed.2021.638194] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
165 Briguglio M, Porta M, Zuffada F, Bona AR, Crespi T, Pino F, Perazzo P, Mazzocchi M, Giorgino R, De Angelis G, Ielasi A, De Blasio G, Turiel M. SARS-CoV-2 Aiming for the Heart: A Multicenter Italian Perspective About Cardiovascular Issues in COVID-19. Front Physiol 2020;11:571367. [PMID: 33240098 DOI: 10.3389/fphys.2020.571367] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
166 Ralli M, Campo F, Angeletti D, Minni A, Artico M, Greco A, Polimeni A, de Vincentiis M. Pathophysiology and therapy of systemic vasculitides. EXCLI J 2020;19:817-54. [PMID: 32665772 DOI: 10.17179/excli2020-1512] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
167 Kuriakose J, Montezano AC, Touyz RM. ACE2/Ang-(1-7)/Mas1 axis and the vascular system: vasoprotection to COVID-19-associated vascular disease. Clin Sci (Lond) 2021;135:387-407. [PMID: 33511992 DOI: 10.1042/CS20200480] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
168 Zhao JV, Schooling CM. Using genetics to understand the role of kidney function in COVID-19: a mendelian randomization study. BMC Nephrol 2021;22:381. [PMID: 34774005 DOI: 10.1186/s12882-021-02586-6] [Reference Citation Analysis]
169 Johny D, Subramanyam K, Baikunje N, Hosmane GB. Cardiac tamponade and massive pleural effusion in a young COVID-19-positive adult. BMJ Case Rep 2021;14:e244518. [PMID: 34518185 DOI: 10.1136/bcr-2021-244518] [Reference Citation Analysis]
170 Emeršič N, Tomaževič T, Točkova O, Kopač M, Volavšek M, Ključevšek D, Avčin T. Case Report: Necrotizing Stomatitis as a Manifestation of COVID-19-Associated Vasculopathy. Front Pediatr 2021;9:800576. [DOI: 10.3389/fped.2021.800576] [Reference Citation Analysis]
171 Magdy Beshbishy A, Oti VB, Hussein DE, Rehan IF, Adeyemi OS, Rivero-Perez N, Zaragoza-Bastida A, Shah MA, Abouelezz K, Hetta HF, Cruz-Martins N, Batiha GE. Factors Behind the Higher COVID-19 Risk in Diabetes: A Critical Review. Front Public Health 2021;9:591982. [PMID: 34307267 DOI: 10.3389/fpubh.2021.591982] [Reference Citation Analysis]
172 Xu J, Xie J, Du B, Tong Z, Qiu H, Bagshaw SM. Clinical Characteristics and Outcomes of Patients With Severe COVID-19 Induced Acute Kidney Injury. J Intensive Care Med 2021;36:319-26. [PMID: 33267722 DOI: 10.1177/0885066620970858] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
173 Milionis C, Milioni SO. A brief analysis and hypotheses about the risk of COVID-19 for people with type 1 and type 2 diabetes mellitus. J Diabetes Metab Disord 2020;:1-5. [PMID: 32837957 DOI: 10.1007/s40200-020-00592-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
174 Feng Z, Bao Y, Yang Y, Zheng Y, Shen K. Severe acute respiratory syndrome coronavirus 2-induced multisystem inflammatory syndrome in children. Pediatr Investig 2020;4:257-62. [PMID: 33376953 DOI: 10.1002/ped4.12225] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
175 Unver E, Kuyrukluyildiz U, Karavas E, Tas HG. Case report: cerebral thromboembolism in an unconscious COVID-19 patient in intensive care. Pan Afr Med J 2021;38:373. [PMID: 34367452 DOI: 10.11604/pamj.2021.38.373.29034] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
176 Matucci-Cerinic M, Hughes M, Taliani G, Kahaleh B. Similarities between COVID-19 and systemic sclerosis early vasculopathy: A "viral" challenge for future research in scleroderma. Autoimmun Rev 2021;20:102899. [PMID: 34274540 DOI: 10.1016/j.autrev.2021.102899] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
177 Sakr Y, Giovini M, Leone M, Pizzilli G, Kortgen A, Bauer M, Tonetti T, Duclos G, Zieleskiewicz L, Buschbeck S, Ranieri VM, Antonucci E. Pulmonary embolism in patients with coronavirus disease-2019 (COVID-19) pneumonia: a narrative review. Ann Intensive Care 2020;10:124. [PMID: 32953201 DOI: 10.1186/s13613-020-00741-0] [Cited by in Crossref: 36] [Cited by in F6Publishing: 41] [Article Influence: 18.0] [Reference Citation Analysis]
178 Figueroa-Pizano MD, Campa-Mada AC, Carvajal-Millan E, Martinez-Robinson KG, Chu AR. The underlying mechanisms for severe COVID-19 progression in people with diabetes mellitus: a critical review. AIMS Public Health 2021;8:720-42. [PMID: 34786431 DOI: 10.3934/publichealth.2021057] [Reference Citation Analysis]
179 Sun Y, Zhao R, Hu Z, Wang W, Wang S, Gao L, Fei J, Jian X, Li Y, Zheng H, Hou X, Chen L. Differences in the Clinical and Hematological Characteristics of COVID-19 Patients with and without Type 2 Diabetes. J Diabetes Res 2020;2020:1038585. [PMID: 33376750 DOI: 10.1155/2020/1038585] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
180 Arigondam AK, Hakeem AR, Reddy MS, Rela M. An Evidence-based Protocol for Minimizing Thromboembolic Events in SARS-CoV-2 Infection. Arch Med Res 2021;52:252-60. [PMID: 33423804 DOI: 10.1016/j.arcmed.2020.11.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
181 Mainali S, Darsie ME. Neurologic and Neuroscientific Evidence in Aged COVID-19 Patients. Front Aging Neurosci 2021;13:648662. [PMID: 33833676 DOI: 10.3389/fnagi.2021.648662] [Reference Citation Analysis]
182 Yang Q, Wijerathne H, Langston JC, Kiani MF, Kilpatrick LE. Emerging Approaches to Understanding Microvascular Endothelial Heterogeneity: A Roadmap for Developing Anti-Inflammatory Therapeutics. Int J Mol Sci 2021;22:7770. [PMID: 34360536 DOI: 10.3390/ijms22157770] [Reference Citation Analysis]
183 Li M, Qian M, Kyler K, Xu J. Adipose Tissue-Endothelial Cell Interactions in Obesity-Induced Endothelial Dysfunction. Front Cardiovasc Med 2021;8:681581. [PMID: 34277732 DOI: 10.3389/fcvm.2021.681581] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
184 Tarnawski AS, Ahluwalia A. Endothelial cells and blood vessels are major targets for COVID-19-induced tissue injury and spreading to various organs. World J Gastroenterol 2022;28:275-89. [PMID: 35110950 DOI: 10.3748/wjg.v28.i3.275] [Reference Citation Analysis]
185 Jiménez D, Torres Arias M. Immunouniverse of SARS-CoV-2. Immunol Med 2022;:1-39. [PMID: 35502127 DOI: 10.1080/25785826.2022.2066251] [Reference Citation Analysis]
186 Stratton CW, Tang YW, Lu H. Pathogenesis-directed therapy of 2019 novel coronavirus disease. J Med Virol 2021;93:1320-42. [PMID: 33073355 DOI: 10.1002/jmv.26610] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
187 Sansone A, Mollaioli D, Limoncin E, Ciocca G, Bắc NH, Cao TN, Hou G, Yuan J, Zitzmann M, Giraldi A, Jannini EA. The Sexual Long COVID (SLC): Erectile Dysfunction as a Biomarker of Systemic Complications for COVID-19 Long Haulers. Sex Med Rev 2021:S2050-0521(21)00085-8. [PMID: 34933829 DOI: 10.1016/j.sxmr.2021.11.001] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
188 García-Mena J, Corona-Cervantes K, Cuervo-Zanatta D, Benitez-Guerrero T, Vélez-Ixta JM, Zavala-Torres NG, Villalobos-Flores LE, Hernández-Quiroz F, Perez-Cruz C, Murugesan S, Bastida-González FG, Zárate-Segura PB. Gut microbiota in a population highly affected by obesity and type 2 diabetes and susceptibility to COVID-19. World J Gastroenterol 2021; 27(41): 7065-7079 [DOI: 10.3748/wjge.v27.i41.7065] [Reference Citation Analysis]
189 Lee CCE, Ali K, Connell D, Mordi IR, George J, Lang EM, Lang CC. COVID-19-Associated Cardiovascular Complications. Diseases 2021;9:47. [PMID: 34209705 DOI: 10.3390/diseases9030047] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
190 Shilts J, Crozier TWM, Greenwood EJD, Lehner PJ, Wright GJ. No evidence for basigin/CD147 as a direct SARS-CoV-2 spike binding receptor. Sci Rep 2021;11:413. [PMID: 33432067 DOI: 10.1038/s41598-020-80464-1] [Cited by in Crossref: 28] [Cited by in F6Publishing: 38] [Article Influence: 28.0] [Reference Citation Analysis]
191 Septyaningtrias DE, Susilowati R. Neurological involvement of COVID-19: from neuroinvasion and neuroimmune crosstalk to long-term consequences. Rev Neurosci 2021;32:427-42. [PMID: 33550780 DOI: 10.1515/revneuro-2020-0092] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
192 Razi M, Gu J, He X, Kong J, Ahmed MJ. Venous thromboembolism in patients with COVID-19. A prevalent and a preventable complication of the pandemic. J Interv Med 2021;4:62-5. [PMID: 34557323 DOI: 10.1016/j.jimed.2021.02.006] [Reference Citation Analysis]
193 Zhang LK, Sun Y, Zeng H, Wang Q, Jiang X, Shang WJ, Wu Y, Li S, Zhang YL, Hao ZN, Chen H, Jin R, Liu W, Li H, Peng K, Xiao G. Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertension. Cell Discov. 2020;6:96. [PMID: 33349633 DOI: 10.1038/s41421-020-00235-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
194 Princiotta Cariddi L, Tabaee Damavandi P, Carimati F, Banfi P, Clemenzi A, Marelli M, Giorgianni A, Vinacci G, Mauri M, Versino M. Reversible Encephalopathy Syndrome (PRES) in a COVID-19 patient. J Neurol 2020;267:3157-60. [PMID: 32583053 DOI: 10.1007/s00415-020-10001-7] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 15.5] [Reference Citation Analysis]
195 Weinbaum S, Cancel LM, Fu BM, Tarbell JM. The Glycocalyx and Its Role in Vascular Physiology and Vascular Related Diseases. Cardiovasc Eng Technol 2021;12:37-71. [PMID: 32959164 DOI: 10.1007/s13239-020-00485-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
196 Drummer C 4th, Saaoud F, Shao (邵颖) Y, Sun (孙宇) Y, Xu (徐克曼) K, Lu (路一凡) Y, Ni (倪栋) D, Atar D, Jiang (蒋晓华) X, Wang (王虹) H, Yang X. Trained Immunity and Reactivity of Macrophages and Endothelial Cells. Arterioscler Thromb Vasc Biol 2021;41:1032-46. [PMID: 33380171 DOI: 10.1161/ATVBAHA.120.315452] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
197 Shen L, Qiu L, Wang L, Huang H, Liu D, Xiao Y, Liu Y, Jin J, Liu X, Wang DW, He B, Zhou N. Statin Use and In-hospital Mortality in Patients with COVID-19 and Coronary Heart Disease. Sci Rep 2021;11:23874. [PMID: 34903765 DOI: 10.1038/s41598-021-02534-2] [Reference Citation Analysis]
198 Tehrani S, Killander A, Åstrand P, Jakobsson J, Gille-Johnson P. Risk factors for death in adult COVID-19 patients: Frailty predicts fatal outcome in older patients. Int J Infect Dis 2021;102:415-21. [PMID: 33130213 DOI: 10.1016/j.ijid.2020.10.071] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 10.5] [Reference Citation Analysis]
199 Volpe N, Ghi T. Re: SARS-CoV-2 behavior, through the eyes of a perinatologist? J Perinat Med 2021. [PMID: 34962365 DOI: 10.1515/jpm-2021-0642] [Reference Citation Analysis]
200 Maurera AH, Vu JH, Rehring TF, Layman PF, Johnson SP. Acute Limb Ischemia in Minimally Symptomatic SARS-CoV-2 Infection. J Vasc Interv Radiol 2020;31:2150-3. [PMID: 33082089 DOI: 10.1016/j.jvir.2020.08.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
201 Almutlaq M, Alamro AA, Alroqi F, Barhoumi T. Classical and Counter-Regulatory Renin-Angiotensin System: Potential Key Roles in COVID-19 Pathophysiology. CJC Open 2021;3:1060-74. [PMID: 33875979 DOI: 10.1016/j.cjco.2021.04.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
202 Cîrstea AE, Buzulică RL, Pirici D, Ceauşu MC, Iman RV, Gheorghe OM, Neamţu SD, Stanca L, Ene R, Kumar-Singh S, Mogoantă L. Histopathological findings in the advanced natural evolution of the SARS-CoV-2 infection. Rom J Morphol Embryol 2020;61:209-18. [PMID: 32747912 DOI: 10.47162/RJME.61.1.23] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
203 Mancini L, Quinzi V, Mummolo S, Marzo G, Marchetti E. Angiotensin-Converting Enzyme 2 as a Possible Correlation between COVID-19 and Periodontal Disease. Applied Sciences 2020;10:6224. [DOI: 10.3390/app10186224] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
204 Wei G, Gu J, Gu Z, Du C, Huang X, Xing H, Li L, Zhang A, Hu X, Huo J. Olfactory Dysfunction in Patients With Coronavirus Disease 2019: A Review. Front Neurol 2022;12:783249. [DOI: 10.3389/fneur.2021.783249] [Reference Citation Analysis]
205 Murala S, Nagarajan E, Bollu PC. Infectious Causes of Stroke. J Stroke Cerebrovasc Dis 2022;31:106274. [PMID: 35093633 DOI: 10.1016/j.jstrokecerebrovasdis.2021.106274] [Reference Citation Analysis]
206 Matsushita K, Marchandot B, Jesel L, Ohlmann P, Morel O. Impact of COVID-19 on the Cardiovascular System: A Review. J Clin Med 2020;9:E1407. [PMID: 32397558 DOI: 10.3390/jcm9051407] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
207 Staub HL, Staub LP. Síndrome inflamatória multissistêmica (SIMS) pós-COVID-19: Um conceito em evolução. Sci Med 2022;32:e42436. [DOI: 10.15448/1980-6108.2022.1.42436] [Reference Citation Analysis]
208 Salaffi F, Carotti M, Tardella M, Borgheresi A, Agostini A, Minorati D, Marotto D, Di Carlo M, Galli M, Giovagnoni A, Sarzi-Puttini P. The role of a chest computed tomography severity score in coronavirus disease 2019 pneumonia. Medicine (Baltimore). 2020;99:e22433. [PMID: 33080676 DOI: 10.1097/md.0000000000022433] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
209 Veyre F, Poulain-Veyre C, Esparcieux A, Monsarrat N, Aouifi A, Lapeze J, Chatelard P. Femoral Arterial Thrombosis in a Young Adult after Nonsevere COVID-19. Ann Vasc Surg 2020;69:85-8. [PMID: 32736027 DOI: 10.1016/j.avsg.2020.07.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
210 Fletcher-Sandersjöö A, Bellander BM. Is COVID-19 associated thrombosis caused by overactivation of the complement cascade? A literature review. Thromb Res 2020;194:36-41. [PMID: 32569879 DOI: 10.1016/j.thromres.2020.06.027] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 24.0] [Reference Citation Analysis]
211 Boknäs N, Laine C, Hillarp A, Macwan AS, Gustafsson KM, Lindahl TL, Holmström M. Associations between hemostatic markers and mortality in COVID-19 – Compounding effects of D-dimer, antithrombin and PAP complex. Thrombosis Research 2022;213:97-104. [DOI: 10.1016/j.thromres.2022.03.013] [Reference Citation Analysis]
212 Hartshorn KL. Innate Immunity and Influenza A Virus Pathogenesis: Lessons for COVID-19. Front Cell Infect Microbiol 2020;10:563850. [PMID: 33194802 DOI: 10.3389/fcimb.2020.563850] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
213 Fiorentino G, Coppola A, Izzo R, Annunziata A, Bernardo M, Lombardi A, Trimarco V, Santulli G, Trimarco B. Effects of adding L-arginine orally to standard therapy in patients with COVID-19: A randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysis. EClinicalMedicine 2021;40:101125. [PMID: 34522871 DOI: 10.1016/j.eclinm.2021.101125] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
214 Galán M, Jiménez-Altayó F. Small Resistance Artery Disease and ACE2 in Hypertension: A New Paradigm in the Context of COVID-19. Front Cardiovasc Med 2020;7:588692. [PMID: 33195477 DOI: 10.3389/fcvm.2020.588692] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
215 Chocron R, Galand V, Cellier J, Gendron N, Pommier T, Bory O, Khider L, Trimaille A, Goudot G, Weizman O, Alsac JM, Geneste L, Schmeltz A, Panagides V, Philippe A, Marsou W, Ben Abdallah I, Deney A, El Batti S, Attou S, Juvin P, Delmotte T, Messas E, Pezel T, Planquette B, Duceau B, Gaussem P, Sutter W, Sanchez O, Waldman V, Diehl JL, Mirault T, Bonnet G, Cohen A, Smadja DM; Critical COVID‐19 France Investigators. Anticoagulation Before Hospitalization Is a Potential Protective Factor for COVID-19: Insight From a French Multicenter Cohort Study. J Am Heart Assoc 2021;10:e018624. [PMID: 33550816 DOI: 10.1161/JAHA.120.018624] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
216 Mishra Y, Pathak BK, Mohakuda SS, Tilak TVSVGK, Sen S, P H, Singh R, Singh AR. Relation of D-dimer levels of COVID-19 patients with diabetes mellitus. Diabetes Metab Syndr 2020;14:1927-30. [PMID: 33035824 DOI: 10.1016/j.dsx.2020.09.035] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
217 Noto PV, Giraffa CM, Ragusa E, Mangano G, Malatino L, Carpinteri G. COVID-19: a single experience in Intermediate Care Unit. Ital J Emerg Med 2020;9. [DOI: 10.23736/s2532-1285.20.00038-5] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
218 Dubois-Silva Á, Barbagelata-López C, Mena Á, Piñeiro-Parga P, Llinares-García D, Freire-Castro S. Pulmonary embolism and screening for concomitant proximal deep vein thrombosis in noncritically ill hospitalized patients with coronavirus disease 2019. Intern Emerg Med 2020;15:865-70. [PMID: 32592114 DOI: 10.1007/s11739-020-02416-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
219 Maddaloni E, D'Onofrio L, Alessandri F, Mignogna C, Leto G, Pascarella G, Mezzaroma I, Lichtner M, Pozzilli P, Agrò FE, Rocco M, Pugliese F, Lenzi A, Holman RR, Mastroianni CM, Buzzetti R; CoViDiab Study Group. Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors: a multicentre retrospective study (CoViDiab II). Cardiovasc Diabetol 2020;19:164. [PMID: 33004045 DOI: 10.1186/s12933-020-01140-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 14.5] [Reference Citation Analysis]
220 Jakhmola S, Indari O, Baral B, Kashyap D, Varshney N, Das A, Chatterjee S, Jha HC. Comorbidity Assessment Is Essential During COVID-19 Treatment. Front Physiol 2020;11:984. [PMID: 32903640 DOI: 10.3389/fphys.2020.00984] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
221 Kumar J, Makheja K, Rahul F, Kumar S, Kumar M, Chand M, Kammawal Y, Khalid D, Jahangir M, Bachani P. Long-Term Neurological Impact of COVID-19. Cureus 2021;13:e18131. [PMID: 34692340 DOI: 10.7759/cureus.18131] [Reference Citation Analysis]
222 Tang X, Zheng F. A review of ischemic stroke in COVID-19: currently known pathophysiological mechanisms. Neurol Sci 2021. [PMID: 34671854 DOI: 10.1007/s10072-021-05679-0] [Reference Citation Analysis]
223 Quitadamo PA, Comegna L, Cristalli P. Anti-Infective, Anti-Inflammatory, and Immunomodulatory Properties of Breast Milk Factors for the Protection of Infants in the Pandemic From COVID-19. Front Public Health 2020;8:589736. [PMID: 33738273 DOI: 10.3389/fpubh.2020.589736] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
224 Bai Y, Liang Y, Wang F, Chen L, Zhao Y, Zhao S, Zhu Y, Dong Y, Liang G, Chen D, Liu L. Clinical course and outcomes of COVID-19 patients with a history of cerebrovascular disease: a retrospective study in Wuhan. Ann Transl Med 2021;9:988. [PMID: 34277788 DOI: 10.21037/atm-21-2237] [Reference Citation Analysis]
225 Fogacci S, Fogacci F, Favari E, Toth PP, Borghi C, Cicero AFG. Management of pregnancy-related hypertensive disorders in patients infected with SARS CoV-2: pharmacological and clinical issues. Eur Heart J Cardiovasc Pharmacother 2021;7:346-51. [PMID: 33155016 DOI: 10.1093/ehjcvp/pvaa105] [Reference Citation Analysis]
226 Guo Z, Jiang S, Li Z, Chen S. Metabolic Syndrome “Interacts” With COVID-19. BIO Integration 2021;1:168-77. [DOI: 10.15212/bioi-2020-0035] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
227 Costa LB, Perez LG, Palmeira VA, Macedo E Cordeiro T, Ribeiro VT, Lanza K, Simões E Silva AC. Insights on SARS-CoV-2 Molecular Interactions With the Renin-Angiotensin System. Front Cell Dev Biol 2020;8:559841. [PMID: 33042994 DOI: 10.3389/fcell.2020.559841] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
228 Andarge E, Fikadu T, Temesgen R, Shegaze M, Feleke T, Haile F, Endashaw G, Boti N, Bekele A, Glagn M. Intention and Practice on Personal Preventive Measures Against the COVID-19 Pandemic Among Adults with Chronic Conditions in Southern Ethiopia: A Survey Using the Theory of Planned Behavior. J Multidiscip Healthc 2020;13:1863-77. [PMID: 33299323 DOI: 10.2147/JMDH.S284707] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
229 Pérez-Belmonte LM, Torres-Peña JD, López-Carmona MD, Ayala-Gutiérrez MM, Fuentes-Jiménez F, Huerta LJ, Muñoz JA, Rubio-Rivas M, Madrazo M, Garcia MG, Montes BV, Sola JF, Ena J, Ferrer RG, Pérez CM, Ripper CJ, Lecumberri JJN, Acedo IEA, Canteli SP, Cosío SF, Martínez FA, Rodríguez BC, Pérez-Martínez P, Ramos-Rincón JM, Gómez-Huelgas R; SEMI-COVID-19 Network. Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study. BMC Med 2020;18:359. [PMID: 33190637 DOI: 10.1186/s12916-020-01832-2] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 15.5] [Reference Citation Analysis]
230 Elmokadem AH, Bayoumi D, El-Morsy A, Ehab A, Abo-Hedibah SA. Relationship of the pulmonary disease severity scoring with thromboembolic complications in COVID-19. Emerg Radiol 2021. [PMID: 34802067 DOI: 10.1007/s10140-021-01998-z] [Reference Citation Analysis]
231 Vishwanathan K, Kambhampati SBS, Vaishya R. Top 100 cited articles on diabetes mellitus and Covid-19: A bibliometric analysis. Diabetes Metab Syndr 2021;15:102160. [PMID: 34245962 DOI: 10.1016/j.dsx.2021.05.033] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
232 Satici C, Demirkol MA, Alkan M, Esatoglu SN. Falsely low values of oxygen saturation measured by pulse oximetry in patients with coronavirus disease 2019. Lung India 2020;37:553-4. [PMID: 33154226 DOI: 10.4103/lungindia.lungindia_392_20] [Reference Citation Analysis]